» Articles » PMID: 24666102

Tumour Characteristics and Surgical Treatment of Renal Cell Carcinoma in Sweden 2005-2010: a Population-based Study from the National Swedish Kidney Cancer Register

Overview
Journal Scand J Urol
Specialty Urology
Date 2014 Mar 27
PMID 24666102
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Tumour characteristics, preoperative work-up and surgical treatment in patients diagnosed with renal cell carcinoma (RCC) between 2005 and 2010, and changes over time were studied in a national population-based cohort.

Material And Methods: The National Swedish Kidney Cancer Register (NSKCR) contains information on histopathology, Fuhrman grade and clinical stage at presentation, and on the preoperative work-up and surgical treatment of patients with RCC. Between 2005 and 2010, 5553 RCC patients were registered in the NSKCR, 99% of those registered in the National Cancer Registry.

Results: During the study period the mean tumour size decreased from 70 to 64 mm (p = 0.024) and the frequency of metastatic RCC decreased from 22% to 15% (p < 0.001). The use of preoperative chest computed tomography increased from 59% to 84%. In total, 4229 (76%) patients were treated with curative intent, 3453 (82%) underwent radical nephrectomy, 606 (14%) partial nephrectomy (PN) and 170 (4%) cryotherapy or radiofrequency ablation. In tumours up to 4 cm, PN was performed in 33% of the surgically treated patients. PN irrespective of size increased from 8% to 20% and laparoscopic nephrectomy increased from 6% to 17% during the period. In patients with metastatic RCC, 55% underwent cytoreductive nephrectomy.

Conclusions: The NSKCR explores population-based data on the clinical handling of patients with RCC. This study, between 2005 and 2010, shows significant decrease in tumour size and metastatic RCC at presentation, a more complete preoperative work-up, and significantly increased use of PN and laparoscopic nephrectomy in Sweden.

Citing Articles

Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.

Jozwik-Plebanek K, Saracyn M, Kolodziej M, Kaminska O, Durma A, Madra W Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770563 PMC: 11678666. DOI: 10.3390/ph17121721.


Diagnostic accuracy of deep learning in detection and prognostication of renal cell carcinoma: a systematic review and meta-analysis.

Chandramohan D, Garapati H, Nangia U, Simhadri P, Lapsiwala B, Jena N Front Med (Lausanne). 2024; 11:1447057.

PMID: 39301494 PMC: 11412207. DOI: 10.3389/fmed.2024.1447057.


HISTOPATHOLOGIC FEATURES OF KIDNEY TUMORS AND COMPARISON OF PATIENTS TREATED WITH RADICAL AND PARTIAL NEPHRECTOMY AT OSIJEK UNIVERSITY HOSPITAL CENTER FROM 2017 UNTIL THE END OF 2021.

Sudarevic B, Pavokovic D, Slobodanac E Acta Clin Croat. 2024; 62(Suppl2):84-94.

PMID: 38966018 PMC: 11221236. DOI: 10.20471/acc.2023.62.s2.12.


Artificial Intelligence in Surgical Training for Kidney Cancer: A Systematic Review of the Literature.

Penaranda N, Eissa A, Ferretti S, Bianchi G, Di Bari S, Farinha R Diagnostics (Basel). 2023; 13(19).

PMID: 37835812 PMC: 10572445. DOI: 10.3390/diagnostics13193070.


Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century.

Tichanek F, Forsti A, Hemminki A, Hemminki O, Hemminki K Cancers (Basel). 2023; 15(10).

PMID: 37345119 PMC: 10216153. DOI: 10.3390/cancers15102782.